Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ND-420, Cisplatin, and Fluorouracil in Localized Esophageal Squamous Cell Carcinoma
NCT02017600Phase 2Terminated
- Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Start
- Aug 2013
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel liposome in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Nang Kuang Pharmaceutical Co., Ltd.. Started Aug 2013; status: terminated.
02
Drugs
docetaxel liposome
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02017600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017600.